cyclosporine and HIV Coinfection

cyclosporine has been researched along with HIV Coinfection in 82 studies

Research

Studies (82)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	19 (23.17)	18.2507
2000's	37 (45.12)	29.6817
2010's	24 (29.27)	24.3611
2020's	2 (2.44)	2.80

Authors

Authors	Studies
He, W; Jiang, S; Lu, H; Pang, X; Xie, F; Yu, L; Zhang, M; Zhang, X; Zhou, L	1
Butlertanaka, EP; Mekata, H; Morizako, N; Okabayashi, T; Saito, A; Shibata, H; Tanaka, YL	1
Barbosa de Sousa, L; Farias, RJM; Gama, MEA; Lobão, NTM; Mendes, R	1
Ambrose, Z; Cohen, R; Fischer, DK; Kline, C; Saito, A; Watkins, SC; Yamashita, M	1
Barrail-Tran, A; Botta-Fridlund, D; Cagnot, C; Canva, V; Coilly, A; Conti, F; D'Alteroche, L; Danjou, H; De Ledinghen, V; Duclos-Vallée, JC; Durand, F; Duvoux, C; Fougerou-Leurent, C; Gelé, T; Goldwirt, L; Houssel-Debry, P; Kamar, N; Laforest, C; Lavenu, A; Leroy, V; Moreno, C; Pageaux, GP; Radenne, S; Samuel, D; Taburet, AM	1
Bobardt, MD; Dumont, JM; Gallay, PA; Ptak, RG; Rosenwirth, B; Vuagniaux, G	1
Hapgood, G; Hoy, JF; Jane, SM; Morrissey, CO	1
Bart, PA; Bellutti Enders, F; Cavassini, M; Cellerai, C; Faouzi, M; Harari, A; Miconnet, I; Ohmiti, K; Pantaleo, G; Perreau, M; Rozot, V; Savoye, AL; Viganò, S	1
Brandariz-Nuñez, A; Diaz-Griffero, F; Fricke, T; Smith, AB; Wang, X	1
Barin, B; Benet, L; Browne, M; Carlson, L; Christians, U; Floren, L; Frassetto, L; Roland, M; Stock, P; Wolfe, A	1
Blondeau, C; Fletcher, AJ; Hilditch, L; Jacques, DA; James, LC; Noursadeghi, M; Price, AJ; Rasaiyaah, J; Selwood, DL; Tan, CP; Towers, GJ	1
Barin, B; Benet, LZ; Browne, M; Frassetto, LA; Roland, M; Stock, PG; Tan-Tam, CC; Wolfe, AR	1
Antonini, TM; Bonhomme-Faivre, L; Coilly, A; Duclos-Vallée, JC; Furlan, V; Haim-Boukobza, S; Roque-Afonso, AM; Samuel, D; Sebagh, M; Taburet, AM; Teicher, E; Vittecoq, D	1
Balazs, AB; Baltimore, D; Cheng, C; Donaldson, M; Duan, L; Foulds, KE; Georgiev, IS; Haase, AT; Joyce, MG; Ko, SY; Kong, WP; Kwong, PD; Mascola, JR; Nabel, GJ; Rao, SS; Roederer, M; Rudicell, RS; Saunders, KO; Schmidt, SD; Todd, JP; Wang, L; Xu, L; Yang, ZY	1
Bhagani, S; Davies, G; Gathogo, E; Harber, M; Hilton, R; Jones, R; Levy, J; Post, FA	1
Godbole, S; Paranjape, R; Pawar, J; Shete, A; Suryawanshi, P; Thakar, M	1
Exton, LS; Kirby, B; Mohd Mustapa, MF; Smith, CH; Warren, RB; Weatherhead, SC; Yesudian, PD	1
Agüero, F; Ambrosioni, J; Brunet, M; Caballero, M; de Lazzari, E; Gallart, T; Gatell, JM; Guardo, AC; López-Diéguez, M; Manzardo, C; Marcos, MÁ; Miró, JM; Mosquera, MM; Muñoz-Fernández, MÁ; Nicolás, D; Plana, M; Sued, O; Tuset, M	1
Bazzani, C; Benucci, M; Caporali, R; Galeazzi, M; Giannitti, C; Manganelli, S; Scarpato, S; Sebastiani, GD	1
Appelbaum, FR; Coombs, RW; Corey, L; Harrington, RD; Malhotra, U; Manley, TJ; McNevin, J; Riddell, SR; Storb, R; Woolfrey, AE	1
Hakii, Y; Kishida, H; Kuroiwa, Y; Kurokawa, T; Nishiyama, T; Yamamoto, R	1
Clavel, F; Dam, E; Hance, AJ; Lecossier, D; Matsuoka, S	1
Barrou, B; Billy, C; Calmus, Y; Conti, F; de Truchis, P; Delahousse, M; Duvivier, C; Fontaine, C; Peytavin, G; Salmon-Céron, D; Teicher, E; Tricot, L; Vittecoq, D; Welker, Y; Zucman, D	1
Bonora, S; D'Avolio, A; Di Biagio, A; Rosso, R; Siccardi, M; Viscoli, C	1
Donahue, JP; Haas, DW; Hulgan, T; Lederman, MM; Pilcher, C; Pu, M; Smeaton, L; Smith, K; Valdez, H; Wang, H	1
Abbara, C; Antonini, T; Bonhomme-Faivre, L; Desbois, D; Duclos-Vallée, JC; Samuel, D; Teicher, E; Vittecoq, D	1
Elewski, BE; Gottlieb, AB; Lebwohl, M; Rosmarin, DM	1
Aberg, J; Balfour, HH; Boden, D; Conrad, A; Hare, CB; Hecht, FM; Hogan, C; Kalayjian, RC; Kilby, JM; Little, S; Markowitz, M; Mildvan, D; Mohri, H; Richman, D; Schafer, K; Vaida, F	1
Hicks, CB	1
Delahousse, M; Glotz, D; Lang, P; Legendre, C; Matignon, M; Peraldi, MN; Pillebout, E; Rondeau, E; Touzot, M; Tricot, L; Viard, JP	1
Martin, L	1
Alstrup, K; Jørgensen, KA; Kangas, I; Laursen, AL	1
Ballarin, R; Cautero, N; Cocchi, S; Codeluppi, M; D'Amico, G; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guaraldi, G; Guerrini, GP; Iemmolo, RM; Mimmo, A; Montalti, R; Rompianesi, G; Serra, V; Smerieri, N; Spaggiari, M; Tarantino, G	1
Plaxco, KW; Ricci, F; Vallée-Bélisle, A	1
Fidler, SJ; Hodgson, TA; Porter, SR; Speight, PM; Weber, JN	1
Cullen, BR	1
Grill, SM; Leelawong, M; Oswald-Richter, K; Unutmaz, D	1
Fabregat, J; Figueras, J; Lladó, L; Rafecas, A; Ramos, E; Rufí, G; Serrano, T; Torras, J; Xiol, X	1
Baluom, M; Benet, LZ; Carlson, L; Christians, U; Frassetto, L; Jacobsen, W; Roland, ME; Stock, PG	1
Bonadies, G; Fedele, S; Lo Muzio, L; Lo Russo, L; Mignogna, MD; Nappa, S	1
Keckesova, Z; Towers, GJ; Ylinen, LM	1
Camerini, D; Choudhary, SK; Planelles, V; Powell, DM; Walker, RM; Walsh, C	1
Collins, MK; Dumont, JM; Ikeda, Y; Noser, JA; Sakuma, R; Towers, GJ	1
Deeks, SG; Hunt, PW	1
Ertl, HC; Lederman, MM; Margolis, DM; Medvik, K; Pollard, R; Pu, M; Rodriguez, B; Sevin, A; Sieg, SF; Smeaton, L; Smith, KY; Tebas, P; Valdez, H; Wang, H	1
Girard, C; Guilhou, JJ	1
Biswas, P; Galli, A; Galli, L; Lazzarin, A; Malnati, M; Tambussi, G; Tassan Din, C; Vecchi, A	1
Boki, K; Ioannidou, P; Karafoulidou, A; Katsarou, O; Linardaki, G	1
Ayala, JM; Azimzadeh, AM; DeMartino, JA; Iliff, S; Kawka, DW; Lu, M; Lyons, K; Miller, GG; Mills, SG; Mudgett, JS; Nguyen, BN; Peterson, LB; Pierson, RN; Schröder, C; Siciliano, SJ; Singer, II; Springer, MS; Wu, G; Zhang, T	1
Adam, RI; Aiken, C; Allen, TM; Allgaier, RL; Brander, C; Brockman, MA; Craggs, SL; Goulder, PJ; Harrer, T; Kelleher, AD; Kuntzen, T; LaBute, MX; Le Gall, S; Li, B; McMichael, AJ; Mueller, SM; Power, KA; Rinaldo, CR; Schneidewind, A; Tung, CS; Yang, R	1
Abouelfath, A; Depont, F; Dupon, M; Dutronc, H; Galpérine, T; Giauque, E; Hébert, G; Moore, N; Ragnaud, JM; Valentino, R; Vargas, F	1
Benet, LZ; Browne, M; Carlson, L; Cheng, A; Frassetto, LA; Roland, ME; Stock, PG; Wolfe, AR	1
Nogrady, B	1
Aeschlimann, C; Bobardt, M; Cielniak, I; Crabbé, R; Dumont, JM; Flisiak, R; Gallay, P; Grosgurin, P; Higersberger, J; Horban, A; Kierkus, J; Nicolas-Métral, V; Porchet, H; Scalfaro, P; Selvarajah, S; Siwak, E; Wiercinska-Drapalo, A	1
Diehl, GE; Littman, DR; Zhang, JX	1
Ferenci, P; Gangl, A; Peck-Radosavljevic, M; Rasoul-Rockenschaub, S; Reiberger, T; Rieger, A	1
Deeg, HJ; Grosse-Wilde, H; Hoy, CA; Huss, R; Ottinger, H	1
Bonham, CA; Thomson, AW	1
Bourinbaiar, AS; Lee-Huang, S	1
Pauza, CD; Streblow, DN	1
Britt, WJ; Cvetkovich, TA; del Cerro, C; DiLoreto, D; Epstein, LG; James, H; Kaneshima, H; Lazar, ES; McCune, JM; Saito, Y	1
Clumeck, N	1
Bevec, D; Billich, A; Mlynar, E; Rosenwirth, B; Steinkasserer, A	1
Durez, P; Farber, CM; Heenen, M; Liesnard, C; Parent, D; Tourne, L; Van Vooren, JP	1
Chen, BK; Kaneshima, H; Kinoshita, S; Nolan, GP	1
Beluffi, G; Caselli, D; Maccabruni, A; Minoli, L	1
Göthel, SF; Marahiel, MA	1
Gregoor, PJ; Ijzermans, JN; van der Ende, ME; van Gelder, T; Weimar, W	1
Lisziewicz, J; Lori, F; Ravot, E	1
Wickware, P	1
Henin, Y; Josef, J; LaVecchio, J; Li, X; Marasco, WA; Mhashilkar, A; Multon, MC; Raab, M; Schweighoffer, F; Stuckert, P; Tocque, B; Venot, C; Zhou, C	1
James, JS	1
Cardella, C; Conly, J; Humar, A; Nguyen, ME; Tseng, A	1
Bart, PA; Capiluppi, B; Champagne, P; Chave, JP; Ciuffreda, D; Ellefsen, K; Harari, A; Lazzarin, A; Pantaleo, G; Rizzardi, GP; Tambussi, G	1
Antinori, A; Chiusolo, P; Cingolani, A; De Luca, A; Laurenti, L; Leone, G; Ortona, L; Piccirillo, N; Rutella, S; Sica, S; Sorà, F	1
Calabrese, LH; Coombs, RW; Fox, L; Johnson, R; Lederman, MM; Mildvan, D; Parekh, N; Schock, B; Spritzler, J; Yen-Lieberman, B	1
Ameisen, JC; Capron, A; Groux, H; Monté, D; Mouton, Y; Torpier, G	1
Allen, BR	1
Hill, F; Jacobson, SK; Karpas, A; Lowdell, M	1

Reviews

13 review(s) available for cyclosporine and HIV Coinfection

Article	Year
Immune-mediated cytopenias in human immunodeficiency virus: the first reported case of idiopathic aplastic anaemia successfully treated with immunosuppression. Internal medicine journal, 2013, Volume: 43, Issue:4 Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Female; HIV Infections; Humans; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Middle Aged; Treatment Outcome	2013
Treatment of rheumatic diseases in patients with HCV and HIV infection. Autoimmunity reviews, 2008, Volume: 8, Issue:2 Topics: Antibodies; Cyclosporine; Hepatitis C, Chronic; HIV Infections; Humans; Rheumatic Diseases; Tumor Necrosis Factor-alpha	2008
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:5 Topics: Adolescent; Adult; Animals; Child; Contraindications; Cyclosporine; Drug Interactions; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension; Kidney Diseases; Pregnancy; Psoriasis	2010
[What's new in dermatological treatments?]. Annales de dermatologie et de venereologie, 2010, Volume: 137 Suppl 4 Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab	2010
Immune-based therapy for HIV infection: are acute and chronic HIV infection different diseases? The Journal of infectious diseases, 2006, Dec-15, Volume: 194, Issue:12 Topics: Cyclosporine; HIV; HIV Infections; Humans; Lymphocyte Activation; T-Lymphocytes; Treatment Outcome	2006
[Psoriasis]. La Revue du praticien, 2006, Dec-15, Volume: 56, Issue:19 Topics: Acitretin; Adrenal Cortex Hormones; Adult; Age Factors; Arthritis, Psoriatic; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; HIV Infections; Humans; Infant; Infant, Newborn; Keratolytic Agents; Methotrexate; Ointments; Phototherapy; Psoriasis; Skin; Time Factors; Vitamins	2006
Cyclosporine-induced apoptosis in CD4+ T lymphocytes and computer-simulated analysis: modeling a treatment scenario for HIV infection. Research in immunology, 1995, Volume: 146, Issue:2 Topics: Animals; Apoptosis; CD4-Positive T-Lymphocytes; Cell Line; Computer Simulation; Cyclosporine; Dogs; Growth Inhibitors; HIV Infections; Humans; Lymphocyte Activation; Lymphocyte Depletion; Models, Biological	1995
Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. Advances in experimental medicine and biology, 1995, Volume: 374 Topics: Animals; Apoptosis; Clinical Trials as Topic; Cyclosporine; HIV; HIV Infections; Humans; Immunosuppressive Agents; Lymphocyte Activation; Tacrolimus	1995
Rational problems associated with the development of cellular approaches in controlling HIV spread. Advances in experimental medicine and biology, 1995, Volume: 374 Topics: Acquired Immunodeficiency Syndrome; Animals; Cell Communication; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; HIV Infections; Humans; Immunity, Cellular; T-Lymphocytes, Cytotoxic	1995
Therapeutic approaches to HIV infection based on virus structure and the host pathogen interaction. Current topics in microbiology and immunology, 1995, Volume: 202 Topics: Antiviral Agents; Cyclosporine; Drug Design; Drug Resistance, Microbial; Gene Products, rev; Genetic Variation; HIV; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Immunologic Factors; rev Gene Products, Human Immunodeficiency Virus; RNA-Directed DNA Polymerase; Virion	1995
Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infection. Advances in neuroimmunology, 1994, Volume: 4, Issue:3 Topics: Animals; Anterior Chamber; Blood-Brain Barrier; Brain Tissue Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease Models, Animal; Fetal Tissue Transplantation; HIV Infections; HIV-1; Humans; Mice; Mice, SCID; Monocytes; Rats; Rats, Nude; Retina; Transplantation, Heterologous; Transplantation, Heterotopic	1994
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cellular and molecular life sciences : CMLS, 1999, Volume: 55, Issue:3 Topics: Bacterial Proteins; Cyclosporine; Evolution, Molecular; Fungal Proteins; HIV Infections; HIV-1; Humans; Immunophilins; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Protein Conformation; Protein Folding; Protein Isoforms; Sirolimus; Structure-Activity Relationship; Tacrolimus; Tacrolimus Binding Proteins	1999
New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomide. Drugs, 1999, Volume: 58, Issue:6 Topics: Cyclosporine; HIV Infections; Humans; Hydroxyurea; Immunosuppressive Agents; Nucleic Acid Synthesis Inhibitors; Thalidomide	1999

Trials

13 trial(s) available for cyclosporine and HIV Coinfection

Article	Year
Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. Biopharmaceutics & drug disposition, 2013, Volume: 34, Issue:8 Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Biological Availability; Cyclopropanes; Cyclosporine; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Nevirapine; Tacrolimus; Young Adult	2013
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:3 Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclosporine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pilot Projects; Ritonavir; Young Adult	2017
Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood, 2008, Oct-15, Volume: 112, Issue:8 Topics: Adult; Antiretroviral Therapy, Highly Active; CD8-Positive T-Lymphocytes; Cyclosporine; Epitopes; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV-1; Humans; Immune System; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Transplantation, Homologous	2008
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. European journal of clinical pharmacology, 2009, Volume: 65, Issue:11 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Enzyme Inhibitors; Female; Flow Cytometry; HIV Infections; Humans; Male; Middle Aged; Young Adult	2009
Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:10 Topics: Adult; Anti-Retroviral Agents; Cyclosporine; Dose-Response Relationship, Drug; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Infections; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Lopinavir; Male; Middle Aged; Peptide Fragments; Pyrimidinones; Ritonavir; Tacrolimus; Treatment Outcome	2009
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. The Journal of infectious diseases, 2010, May-01, Volume: 201, Issue:9 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclosporine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Male; Viral Load	2010
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138. The Journal of infectious diseases, 2006, Dec-15, Volume: 194, Issue:12 Topics: Adult; Anti-Retroviral Agents; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Receptors, Chemokine; T-Lymphocytes; Treatment Outcome	2006
Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients? Cytometry. Part B, Clinical cytometry, 2007, Volume: 72, Issue:6 Topics: Adult; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokine CCL5; Cyclosporine; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Receptors, CCR5; Receptors, CXCR4	2007
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:12 Topics: Adult; Anti-Retroviral Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Pilot Projects; Sirolimus; Tacrolimus	2007
The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:3 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cyclophilin A; Cyclophilins; Cyclosporine; Double-Blind Method; Drug Resistance, Viral; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Male; Middle Aged; Peptidylprolyl Isomerase; Placebos; Virus Replication	2008
Trial will evaluate cyclosporine. AIDS patient care and STDs, 1999, Volume: 13, Issue:3 Topics: Cyclosporine; Drug Evaluation; HIV Infections; Humans; Immunosuppressive Agents	1999
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. The Journal of clinical investigation, 2002, Volume: 109, Issue:5 Topics: Adjuvants, Immunologic; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclosporine; HIV Infections; HIV-1; Humans; Middle Aged; Prospective Studies; Receptors, CCR7; Receptors, Chemokine; Safety; T-Lymphocyte Subsets; Virus Replication	2002
Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation. Journal of acquired immune deficiency syndromes (1999), 2002, Apr-01, Volume: 29, Issue:4 Topics: Adult; CD4 Lymphocyte Count; Cyclosporine; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Male; Organ Transplantation; RNA, Viral; Treatment Outcome	2002

Other Studies

56 other study(ies) available for cyclosporine and HIV Coinfection

Article	Year
Discovery of a potent peptidic cyclophilin A inhibitor Trp-Gly-Pro. European journal of medicinal chemistry, 2011, Volume: 46, Issue:5 Topics: Binding Sites; Cell Line, Transformed; Cyclophilin A; Dose-Response Relationship, Drug; Drug Discovery; HIV Infections; HIV-1; Humans; Models, Molecular; Oligopeptides; Structure-Activity Relationship; Virus Replication	2011
Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector. Scientific reports, 2022, 10-18, Volume: 12, Issue:1 Topics: Animals; Cattle; Cell Line; Cyclosporine; HIV Infections; HIV-1; Humans; Macaca mulatta; Mammals; Tripartite Motif Proteins; Ubiquitin-Protein Ligases	2022
Vernal Keratoconjunctivitis as the Only Clinical Manifestation of HIV Infection. Ocular immunology and inflammation, 2022, Volume: 30, Issue:6 Topics: Adrenal Cortex Hormones; Child; Conjunctivitis, Allergic; Cyclosporine; HIV Infections; Humans; Male; Ophthalmic Solutions	2022
CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes. Journal of virology, 2019, 05-01, Volume: 93, Issue:9 Topics: Active Transport, Cell Nucleus; Amino Acid Substitution; Capsid; CD4-Positive T-Lymphocytes; Cell Nucleus; Cyclosporine; HEK293 Cells; HeLa Cells; HIV Infections; HIV-1; Humans; Mutation, Missense; Viral Proteins; Virus Uncoating	2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort. European journal of clinical pharmacology, 2019, Volume: 75, Issue:11 Topics: Aged; Anemia; Antiviral Agents; Carbamates; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Tacrolimus; Valine	2019
Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms. Viruses, 2013, Mar-22, Volume: 5, Issue:3 Topics: Amino Acid Sequence; Anti-HIV Agents; Capsid; Capsid Proteins; Cyclosporine; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation, Missense; Polymorphism, Genetic	2013
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells. PLoS pathogens, 2013, Volume: 9, Issue:7 Topics: Anti-Retroviral Agents; Antibodies, Viral; Antibody Affinity; CD8-Positive T-Lymphocytes; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Disease Progression; Epitope Mapping; HIV; HIV Infections; Humans; Immunity, Cellular; Immunosuppressive Agents; Longitudinal Studies; Receptors, Antigen, T-Cell; Up-Regulation; Viremia; Virus Replication	2013
Human cytosolic extracts stabilize the HIV-1 core. Journal of virology, 2013, Volume: 87, Issue:19 Topics: Blotting, Western; Capsid; Cyclosporine; Cytosol; gag Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Mutagenesis, Site-Directed; Mutation; Nucleocapsid; Peptide Fragments; Virion; Virus Assembly	2013
HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature, 2013, Nov-21, Volume: 503, Issue:7476 Topics: Capsid Proteins; Cyclophilins; Cyclosporine; HIV Infections; HIV-1; Humans; Immune Evasion; Immunity, Innate; Interferon Regulatory Factor-3; Interferon Type I; Macrophages; Molecular Chaperones; Monocytes; mRNA Cleavage and Polyadenylation Factors; NF-kappa B; Nuclear Pore Complex Proteins; Receptors, Pattern Recognition; Virus Internalization; Virus Replication	2013
Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. Transplantation, 2014, Mar-27, Volume: 97, Issue:6 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Area Under Curve; Chromatography, Liquid; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Graft Rejection; HIV Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Tacrolimus; Tandem Mass Spectrometry; Treatment Outcome; Young Adult	2014
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. AIDS (London, England), 2015, Jan-02, Volume: 29, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppression Therapy; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load	2015
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection. Journal of virology, 2015, Volume: 89, Issue:16 Topics: Amino Acid Sequence; Animals; Antibodies, Neutralizing; Cyclosporine; DNA Primers; Enzyme-Linked Immunosorbent Assay; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoglobulin G; Immunosuppressive Agents; Macaca mulatta; Models, Molecular; Molecular Sequence Data; Neutralization Tests; Real-Time Polymerase Chain Reaction	2015
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. Transplantation, 2016, Volume: 100, Issue:4 Topics: Acute Disease; Aged; Allografts; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HIV Infections; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Patient Selection; Proportional Hazards Models; Risk Assessment; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; United Kingdom	2016
HIV-infected CD4+ T Cells Use T-bet-dependent Pathway for Production of IL-10 Upon Antigen Recognition. Scandinavian journal of immunology, 2016, Volume: 83, Issue:4 Topics: Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Forkhead Transcription Factors; HIV Core Protein p24; HIV Infections; Humans; Interferon-gamma; Interleukin-10; Lymphocyte Activation; Male; Middle Aged; Quinolones; T-Box Domain Proteins; Young Adult	2016
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. The British journal of dermatology, 2016, Volume: 175, Issue:1 Topics: Adult; Alcohol Drinking; Biological Products; Bone Marrow Diseases; Checklist; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Monitoring; Drug Overdose; Evidence-Based Medicine; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Intraoperative Complications; Kidney Diseases; Lung Diseases; Methotrexate; Nausea; Neoplasms; Off-Label Use; Patient Education as Topic; Patient Safety; Pregnancy; Pregnancy Complications; Retinoids; Skin Diseases; Tuberculosis; Ultraviolet Rays; Vaccination	2016
[Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report]. Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:9 Topics: Autoantibodies; Cyclosporine; HIV Infections; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome	2008
Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type. Retrovirology, 2009, Mar-02, Volume: 6 Topics: Antiviral Restriction Factors; Carrier Proteins; Cell Line; Cyclophilin A; Cyclosporine; Enzyme Inhibitors; gag Gene Products, Human Immunodeficiency Virus; Gene Expression; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Protein Binding; Tripartite Motif Proteins; Ubiquitin-Protein Ligases	2009
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:8 Topics: Adult; Anti-Retroviral Agents; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Female; Graft Rejection; HIV Infections; HIV Integrase; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Pyrrolidinones; Raltegravir Potassium; Retrospective Studies; Tacrolimus; Treatment Outcome	2009
Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4 Topics: Anti-HIV Agents; Cyclosporine; Drug Interactions; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Pyrrolidinones; Raltegravir Potassium; Serum; Transplantation	2009
Cyclosporine in acute and early HIV infection. Journal watch. AIDS clinical care, 2010, Volume: 22, Issue:6 Topics: Antiretroviral Therapy, Highly Active; Cyclosporine; HIV Infections; HIV-1; Humans	2010
Renal transplantation in HIV-infected patients: the Paris experience. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:10 Topics: Adult; Cyclosporine; Female; Graft Rejection; Graft Survival; HIV Infections; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Paris; Retrospective Studies; Tacrolimus	2010
Renal transplantation in an HIV-infected patient: pharmacokinetic aspects. Scandinavian journal of urology and nephrology, 2011, Volume: 45, Issue:3 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Area Under Curve; Cyclosporine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; HIV Infections; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male	2011
University of Modena experience in HIV-positive patients undergoing liver transplantation. Transplantation proceedings, 2011, Volume: 43, Issue:4 Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Cyclosporine; Drug Substitution; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals, University; Humans; Immunosuppressive Agents; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Severity of Illness Index; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome; Viral Load	2011
Engineering biosensors with extended, narrowed, or arbitrarily edited dynamic range. Journal of the American Chemical Society, 2012, Feb-15, Volume: 134, Issue:6 Topics: Aminoglycosides; Binding Sites; Biomechanical Phenomena; Biosensing Techniques; Cyclosporine; Engineering; Fluorescent Dyes; HIV Infections; Humans; Kinetics; Nucleic Acids; Protein Folding; Signal Transduction; Spectrometry, Fluorescence	2012
Oral pemphigus vulgaris associated with HIV infection. Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:2 Topics: Adult; Antiretroviral Therapy, Highly Active; Cyclosporine; Disease Progression; HIV Infections; Humans; Immunosuppressive Agents; Male; Pemphigus	2003
HIV-1 infection: fooling the gatekeeper. Nature medicine, 2003, Volume: 9, Issue:9 Topics: Animals; Cyclophilin A; Cyclosporine; DNA-(Apurinic or Apyrimidinic Site) Lyase; Genetic Predisposition to Disease; HIV Infections; HIV-1; Humans; Leukemia Virus, Murine; Mice; Primates; Proteins; Retroviridae; Virion	2003
HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. European journal of immunology, 2004, Volume: 34, Issue:6 Topics: CD4-Positive T-Lymphocytes; Cell Division; Cyclosporine; DNA-Binding Proteins; HIV; HIV Infections; Humans; Kinetics; Lymphocyte Activation; NFATC Transcription Factors; Nuclear Proteins; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Signal Transduction; Sirolimus; Tacrolimus; Transcription Factors; Virus Replication	2004
Liver transplantation without steroid induction in HIV-infected patients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiretroviral Therapy, Highly Active; Basiliximab; Contraindications; Cyclosporine; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Recombinant Fusion Proteins; Spain; Steroids	2004
Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation, 2005, Jul-15, Volume: 80, Issue:1 Topics: Adolescent; Adult; Anti-HIV Agents; Cyclosporine; Female; HIV Infections; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Treatment Failure; Treatment Outcome	2005
Acute cyclosporine nephrotoxicity in a patient with oral pemphigus vulgaris and HIV infection on antiretroviral therapy. Journal of the American Academy of Dermatology, 2005, Volume: 53, Issue:6 Topics: Acute Disease; Adult; Antiretroviral Therapy, Highly Active; Cyclosporine; HIV Infections; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Mouth Diseases; Pemphigus	2005
Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. Journal of virology, 2006, Volume: 80, Issue:10 Topics: Animals; Anti-HIV Agents; Antiviral Restriction Factors; Carrier Proteins; Cats; Cell Line; Cercopithecidae; Cyclophilin A; Cyclosporine; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Leukemia Virus, Murine; Simian Immunodeficiency Virus; Tripartite Motif Proteins; Ubiquitin-Protein Ligases	2006
CXCR4 tropic human immunodeficiency virus type 1 induces an apoptotic cascade in immature infected thymocytes that resembles thymocyte negative selection. Virology, 2006, Sep-01, Volume: 352, Issue:2 Topics: Apoptosis; Caspases; CD4 Antigens; CD8 Antigens; Cell Differentiation; Cyclosporine; Flavonoids; Gene Expression; HIV Infections; HIV-1; Humans; In Vitro Techniques; Protein Biosynthesis; Receptors, CXCR4; T-Lymphocytes; Virus Replication	2006
Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. Journal of virology, 2006, Volume: 80, Issue:15 Topics: Animals; Bone Marrow; Cyclophilin A; Cyclosporine; Drug Resistance, Viral; Female; Genetic Vectors; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Lentivirus; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Simian Immunodeficiency Virus; Transduction, Genetic; Vesicular stomatitis Indiana virus; Virus Replication	2006
Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. The Journal of rheumatology, 2007, Volume: 34, Issue:6 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Hepatitis C; HIV Infections; Humans; Immunoglobulin G; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2007
CCR5 blockade modulates inflammation and alloimmunity in primates. Journal of immunology (Baltimore, Md. : 1950), 2007, Aug-15, Volume: 179, Issue:4 Topics: Animals; Antibody Formation; Autoimmunity; CCR5 Receptor Antagonists; Cyclosporine; Disease Models, Animal; Graft Survival; Heart Transplantation; HIV Infections; Humans; Immunosuppressive Agents; Inflammation; Isoantibodies; Kidney Transplantation; Macaca fascicularis; Macrophages; Male; Pyrazoles; Stress, Physiological; T-Lymphocytes; Transplantation Tolerance; Transplantation, Homologous; Valine; Vascular Diseases	2007
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Journal of virology, 2007, Volume: 81, Issue:22 Topics: Amino Acid Sequence; Capsid; Cyclosporine; gag Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; HLA-B27 Antigen; Humans; Immunodominant Epitopes; Molecular Sequence Data; Mutation; T-Lymphocytes, Cytotoxic; Virus Replication	2007
Drug-drug interactions with systemic antifungals in clinical practice. Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:11 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Creatinine; Cyclosporine; Drug Interactions; Female; Fluconazole; France; Furosemide; HIV Infections; Hospitals, University; Humans; Hydrocortisone; Hypokalemia; Intensive Care Units; Itraconazole; Kidney Diseases; Leukemia; Male; Middle Aged; Neoplasms; Retrospective Studies	2007
T cell turnoff. Scientific American, 2007, Volume: 297, Issue:6 Topics: Anti-Retroviral Agents; CD4-Positive T-Lymphocytes; Cyclosporine; HIV Infections; Humans; Immunosuppressive Agents; Lymphocyte Count; T-Lymphocytes	2007
Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PloS one, 2008, Apr-30, Volume: 3, Issue:4 Topics: Active Transport, Cell Nucleus; Animals; CD4 Antigens; Cell Nucleus; Cells, Cultured; Cyclin T; Cyclins; Cyclosporine; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Mice; Mice, Transgenic; Protein Biosynthesis; Receptors, Antigen, T-Cell; Receptors, CCR5; Reverse Transcription; Signal Transduction; Species Specificity; T-Lymphocytes; Virus Integration; Virus Internalization; Virus Replication	2008
Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection. European journal of clinical investigation, 2008, Volume: 38, Issue:6 Topics: Adult; Aged; Antiviral Agents; Calcineurin Inhibitors; CD4 Lymphocyte Count; Cyclosporine; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Statistics, Nonparametric; Tacrolimus; Treatment Outcome; Viral Load	2008
[Human immunodeficiency virus infection: physiopathological approach to specific therapeutic strategies]. Revue medicale de Bruxelles, 1996, Volume: 17, Issue:4 Topics: CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; HIV; HIV Infections; Humans; Immunosuppressive Agents; Interleukin-2; Tumor Necrosis Factor-alpha; Virus Replication	1996
The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells. The Journal of general virology, 1997, Volume: 78 ( Pt 4) Topics: Anti-HIV Agents; Cell Division; Cyclosporine; Drug Interactions; HIV Infections; HIV-1; Humans; T-Lymphocytes; Virion; Virus Replication	1997
Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine. Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:3 Pt 1 Topics: Adult; Arthritis, Psoriatic; Cyclosporine; HIV Infections; Humans; Male; Psoriasis	1997
Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell, 1998, Nov-25, Volume: 95, Issue:5 Topics: CD4-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Cyclosporine; DNA-Binding Proteins; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Immunosuppressive Agents; Lymphocyte Activation; NFATC Transcription Factors; Nuclear Proteins; Phytohemagglutinins; T-Lymphocytes; Transcription Factors; Virus Replication	1998
Cyclosporine for rectoperineal fistula in a human immunodeficiency virus-infected child. Journal of pediatric gastroenterology and nutrition, 1999, Volume: 28, Issue:3 Topics: Adolescent; Antiviral Agents; Burkitt Lymphoma; Child; Cyclosporine; Fistula; HIV Infections; Humans; Male; Perineum; Rectal Fistula	1999
Cyclosporine and triple-drug treatment with human immunodeficiency virus protease inhibitors. Transplantation, 1999, Oct-27, Volume: 68, Issue:8 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Immunosuppressive Agents	1999
$1 million study renews HIV/transplant research. Nature medicine, 2000, Volume: 6, Issue:4 Topics: Cyclosporine; Graft Rejection; HIV Infections; Humans; Immunosuppressive Agents; Organ Transplantation	2000
Grb3-3 is up-regulated in HIV-1-infected T-cells and can potentiate cell activation through NFATc. The Journal of biological chemistry, 2000, Oct-06, Volume: 275, Issue:40 Topics: Adaptor Proteins, Signal Transducing; Adult; Antibodies, Monoclonal; Blotting, Western; CD28 Antigens; CD4-Positive T-Lymphocytes; Cell Nucleus; Cyclosporine; Cytoplasm; DNA-Binding Proteins; Female; Gene Products, nef; Gene Products, tat; GRB2 Adaptor Protein; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Jurkat Cells; Leukocytes, Mononuclear; Luciferases; Male; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Middle Aged; nef Gene Products, Human Immunodeficiency Virus; NFATC Transcription Factors; Nuclear Proteins; Plasmids; Promoter Regions, Genetic; Protein Isoforms; Protein Serine-Threonine Kinases; Proteins; Receptors, Antigen, T-Cell; RNA, Messenger; Signal Transduction; tat Gene Products, Human Immunodeficiency Virus; Terminal Repeat Sequences; Time Factors; Transcription Factor AP-1; Transcription Factors; Transfection; Up-Regulation	2000
Low-dose cyclosporin: government trial recruiting, CD4 count over 500. AIDS treatment news, 1998, Dec-04, Issue:No 308 Topics: CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Cyclosporine; HIV Infections; Humans; Immunosuppressive Agents; Patient Selection; United States; Viral Load	1998
San Franscisco area: important cyclosporin study recruiting. AIDS treatment news, 1999, Mar-19, Issue:No 315 Topics: Clinical Trials as Topic; Cyclosporine; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Immunosuppressive Agents; Patient Selection; San Francisco	1999
Transplanted livers and kidneys for HIV+ people. TreatmentUpdate, 2001,Spring, Volume: 12, Issue:12 Topics: Antiretroviral Therapy, Highly Active; Cyclosporine; Hepatitis B; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Kidney Transplantation; Liver Failure; Liver Transplantation; Lovastatin; Pravastatin; Renal Insufficiency; San Francisco	2001
Probable interaction between efavirenz and cyclosporine. AIDS (London, England), 2002, Feb-15, Volume: 16, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cyclosporine; Drug Interactions; HIV Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Oxazines	2002
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia. Experimental hematology, 2002, Volume: 30, Issue:3 Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatitis C; HIV; HIV Infections; Humans; Leukemia, Myeloid, Acute; Remission Induction; RNA, Viral; Transplantation, Homologous; Viremia	2002
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. The Journal of experimental medicine, 1992, Feb-01, Volume: 175, Issue:2 Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD28 Antigens; CD4-Positive T-Lymphocytes; Cell Death; Cycloheximide; Cyclosporine; Electrophoresis, Agar Gel; Enterotoxins; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lymphocyte Activation; Male; Mitogens; Receptors, Antigen, T-Cell, alpha-beta	1992
Use of cyclosporin for psoriasis in HIV-positive patient. Lancet (London, England), 1992, Mar-14, Volume: 339, Issue:8794 Topics: Contraindications; Cyclosporine; HIV Infections; Humans; Male; Middle Aged; Psoriasis	1992
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proceedings of the National Academy of Sciences of the United States of America, 1992, Sep-01, Volume: 89, Issue:17 Topics: CD4 Antigens; Cell Division; Cell Fusion; Cyclosporine; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; In Vitro Techniques; T-Lymphocytes; Tacrolimus	1992